Alfred D. Kingsley, Director at Asterias Biotherapeutics, Inc. (AST), bought 4,000 shares at $2.93 ($12K) on 2016-06-09, disclosed to the SEC on 2016-06-10.
Open-market purchase of $12k AST by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| OCX | BUY | 2022-08-17 | $5K | — | Filing → |
| OCX | SELL | 2020-12-28 | $2K | — | Filing → |
| OCX | SELL | 2020-12-23 | $13K | — | Filing → |